FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised a seed round / Biotech startups that raised a seed round in the United States

Biotech startups that raised a seed round in the United States

Updated 16 Nov 2026

Reset
Biotech startups that raised a seed round in the United States
One-time CSV
  • 1,942 funded companies, 1,470 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--seed~united-states.csv1,942 rows × 18 columns
CompanyCityLast roundAmountDate
WelltoryRedwood CitySeed$2.0M2026-10-08
Talus BioSeattleSeed$11.2M2026-09-21
heXem bioNew YorkSeed$10.4M2026-09-15
PGxAIPalo AltoSeed$3.0M2026-09-14
Navion NeurosciencesCharlottesvilleSeed$10.8M2026-09-09
Cloverleaf BioNew HavenSeed$33.0M2026-09-08
INIA BiosciencesBostonSeed$1.5M2026-09-08
RybodynSan DiegoSeed$1.3M2026-07-23

8 rows of the CSV in 5 of its 18 columns.

startups-biotech--seed~united-states-contacts.csvUp to 2 verified founders or CEOs per company × 7 columns
CompanyPersonTitleVerified emailLinkedIn
Eugit Therapeutics, IncG••• A•••General Partnerg•••@ycombinator.comIn the CSV
AVLabB••• B•••Founder, Managing Partnerb•••@analyticsventures.comIn the CSV
Prime Movers LabA••• K•••General Partner & Chief Investment Officer - Satori Neuroa•••@primemoverslab.comIn the CSV

3 verified founder and CEO contact rows from organizations on this list, names and emails masked.

1,942
Startups
$6.7B
Total raised
267
Funded in the last 12 months
$1.8B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 1,942
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Welltory Welltory produces AI-powered wellness apps for digital health tracking. Artificial intelligence Redwood City Seed $2.0M 2026-10-08 $16.3M Goodwater Capital, JOINT JOURNEY, CABRA VC 51 to 100 2016
Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
PGxAI PGxAI provides a clinical decision support platform for pharmacogenomics, medication safety, and real-world evidence. Artificial intelligence Palo Alto Seed $3.0M 2026-09-14 $5.0M ATEM Capital Fund LP 11 to 50 2023
Navion Neurosciences Navion Neurosciences develops sodium channel therapeutics for neurological diseases at a pre-clinical stage. Artificial intelligence Charlottesville Seed $10.8M 2026-09-09 $21.2M Virginia Innovation Partnership Corporation, 3B Future Health Fund, UVA Licensing & Ventures Group +1 1 to 10 2021
Cloverleaf Bio Cloverleaf Bio develops an RNA therapeutic platform for oncology. Biotech New Haven Seed $33.0M 2026-09-08 $33.0M Mission BioCapital 1 to 10 2023
INIA Biosciences INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. Biotech Boston Seed $1.5M 2026-09-08 $1.5M MassChallenge, MedTech Innovator 1 to 10 2020
Rybodyn Rybodyn develops therapeutics that train the immune system to detect and eradicate cancer. Biotech San Diego Seed $1.3M 2026-07-23 $15.3M SOSV, SOSV SF & NY (Fka IndieBio) 11 to 50 2022
ElectroKare ElectroKare builds computational models that simulate human physiological systems and processes. Artificial intelligence New York Seed $4.0M 2026-07-01 $4.0M iVenture Accelerator, Techstars Physical Health, Fort Worth, Texas 11 to 50 2025
Portal Portal engineers cells to develop new treatments and therapies. Biotech Watertown Seed $9.0M 2026-06-18 $25.7M Pear VC, Page One Ventures, IA Ventures +2 11 to 50 2023
Kopra Bio Kopra Bio develops viral immunotherapy treatments to cure cancer. Biotech San Francisco Seed $9.1M 2026-06-16 $9.7M Y Combinator, Pioneer Fund 1 to 10 2024
Kimba Kimba uses AI to analyze biometric data and deliver personalized scent treatments for better sleep and health. Artificial intelligence New York Seed $5.4M 2026-06-16 $6.4M Techstars 1 to 10 2024
Century Health Century Health applies AI to real-world clinical data to accelerate drug development and commercialization. Artificial intelligence New York Seed $5.0M 2026-05-19 $7.0M Alumni Ventures, Everywhere Ventures, 2048 Ventures +1 1 to 10 2023
Auxilium Health Auxilium Health develops low-cost, smart biomaterials for wounds that are difficult to heal. Biotech Akron Seed $3.0M 2026-05-15 $5.0M Ohio Third Frontier 1 to 10 2022
ParcelBio ParcelBio develops RNA medicine delivery systems and therapeutic development platforms. Biotech San Francisco Seed $13.0M 2026-05-07 $13.5M Y Combinator, Alumni Ventures, Pioneer Fund +2 1 to 10 2024
Modicus Prime Modicus Prime enables pharmaceutical manufacturers to deploy auditable and compliant AI systems. Artificial intelligence Austin Seed $4.5M 2026-05-06 $9.2M Techstars, Plug and Play, Alumni Ventures +2 11 to 50 2020
Fermeate Fermeate provides photomolecular fermentation technology that makes biomanufacturing more sustainable and efficient. Biotech San Francisco Seed $2.5M 2026-04-27 $2.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
TippingPoint Biosciences TippingPoint Biosciences develops therapeutics that target genome packaging states in diseases such as cancer. Biotech San Francisco Seed $4.5M 2026-03-31 $4.5M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2022
BioLattice BioLattice develops tissue healing solutions. Biotech Philadelphia Seed $575K 2026-03-30 $585K SOSV, SOSV SF & NY (Fka IndieBio), Startup302 1 to 10 2017
Gelmedix Gelmedix develops a biomaterial platform that improves drug delivery for complex eye treatments. Biotech Newton Seed $13.0M 2026-02-17 $15.4M Safar Partners, EQx Fund, HTL Innovations 1 to 10 2020
Avenue Biosciences Avenue Biosciences is a transatlantic biotech company specializing in protein engineering technologies. Biotech Palo Alto Seed $7.4M 2026-01-12 $9.9M Inventure, Voima Ventures 11 to 50 2023
NANOCHON Nanochon develops medical implant technology for repairing cartilage in patients with joint surface damage. Biotech Washington Seed $4.1M 2026-01-12 $14.3M Alumni Ventures, MassChallenge, National Science Foundation +2 1 to 10 2016
STRM.BIO STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. Biotech Cambridge Seed $8.0M 2026-01-07 $10.1M Bill & Melinda Gates Foundation, NYBC Ventures, NCATS 11 to 50 2019
Ligo Biosciences Ligo Biosciences develops deep-learning models for enzyme design to lower the cost of chemical manufacturing. Biotech San Francisco Seed $500K 2026-01-01 $500K Y Combinator 1 to 10 2024
1849 Bio 1849 Bio creates microbes that extract metals affordably from low-grade copper and gold ores. Biotech San Francisco Seed $500K 2026-01-01 $500K Y Combinator 1 to 10 2024
Biometry Biometry develops diagnostic tools for patients with chronic respiratory conditions. Artificial intelligence Boston Seed $2.2M 2025-12-19 $7.8M MassChallenge, Elevate Ventures, Sidecar Angels +1 11 to 50 2013
Feanix Biotechnologies Feanix Biotechnologies operates a genetic laboratory that tests samples. Biotech Asheville Seed $5.3M 2025-12-18 $5.8M Y Combinator 11 to 50 2024
Cayuga Biotech Cayuga Biotech develops hemostatic drugs and devices for treating bleeding episodes. Biotech Bridgewater Seed $5.0M 2025-12-11 $8.2M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2015
NeuroBionics NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. Biotech Cambridge Seed $4.2M 2025-12-10 $9.2M MedTech Innovator, Dolby Family Ventures, GreyMatter +1 1 to 10 2023
OncoPrecision OncoPrecision develops patient-centric therapeutic antibodies. Biotech New York Seed $4.5M 2025-11-24 $11.1M SOSV, SOSV SF & NY (Fka IndieBio), GRID EXPONENTIAL +2 11 to 50 2020

Table 1. Biotech startups that raised a seed round in the United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 1,942.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Cloverleaf Bio Cloverleaf Bio develops an RNA therapeutic platform for oncology. Biotech New Haven Seed $33.0M 2026-09-08 $33.0M Mission BioCapital 1 to 10 2023
2 ParcelBio ParcelBio develops RNA medicine delivery systems and therapeutic development platforms. Biotech San Francisco Seed $13.0M 2026-05-07 $13.5M Y Combinator, Alumni Ventures, Pioneer Fund +2 1 to 10 2024
3 Gelmedix Gelmedix develops a biomaterial platform that improves drug delivery for complex eye treatments. Biotech Newton Seed $13.0M 2026-02-17 $15.4M Safar Partners, EQx Fund, HTL Innovations 1 to 10 2020
4 Talus Bio Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. Artificial intelligence Seattle Seed $11.2M 2026-09-21 $27.8M Y Combinator, Pioneer Fund, National Science Foundation +2 11 to 50 2020
5 Navion Neurosciences Navion Neurosciences develops sodium channel therapeutics for neurological diseases at a pre-clinical stage. Artificial intelligence Charlottesville Seed $10.8M 2026-09-09 $21.2M Virginia Innovation Partnership Corporation, 3B Future Health Fund, UVA Licensing & Ventures Group +1 1 to 10 2021
6 heXem bio HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells and extend healthy lifespan. Biotech New York Seed $10.4M 2026-09-15 $10.4M SOSV, SOSV SF & NY (Fka IndieBio) 1 to 10 2024
7 Kopra Bio Kopra Bio develops viral immunotherapy treatments to cure cancer. Biotech San Francisco Seed $9.1M 2026-06-16 $9.7M Y Combinator, Pioneer Fund 1 to 10 2024
8 Portal Portal engineers cells to develop new treatments and therapies. Biotech Watertown Seed $9.0M 2026-06-18 $25.7M Pear VC, Page One Ventures, IA Ventures +2 11 to 50 2023
9 STRM.BIO STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. Biotech Cambridge Seed $8.0M 2026-01-07 $10.1M Bill & Melinda Gates Foundation, NYBC Ventures, NCATS 11 to 50 2019
10 Avenue Biosciences Avenue Biosciences is a transatlantic biotech company specializing in protein engineering technologies. Biotech Palo Alto Seed $7.4M 2026-01-12 $9.9M Inventure, Voima Ventures 11 to 50 2023

Table 2. Biotech startups that raised a seed round in the United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Y Combinator Startup accelerator Mountain View, United States 30 2% 7 Talus Bio, Kopra Bio, ParcelBio
2 SOSV Venture capital firm Princeton, United States 23 1% 9 heXem bio, Farm Minerals, Rybodyn
3 SOSV SF & NY (Fka IndieBio) Venture capital firm San Francisco, United States 20 1% 9 heXem bio, Farm Minerals, Rybodyn
4 National Science Foundation Entrepreneurship program Alexandria, United States 18 1% 2 Talus Bio, NANOCHON
5 Pioneer Fund Startup accelerator Toronto, Canada 11 1% 4 Talus Bio, Kopra Bio, ParcelBio
6 Alumni Ventures Angel group Manchester, United States 10 1% 4 Century Health, ParcelBio, Modicus Prime
7 MassChallenge Startup accelerator Boston, United States 8 0% 3 INIA Biosciences, NANOCHON, Biometry
8 Techstars Startup accelerator New York, United States 8 0% 2 Kimba, Modicus Prime
9 Plug and Play Startup accelerator Sunnyvale, United States 7 0% 2 WittGen Biotechnologies, Modicus Prime
10 MedTech Innovator Startup accelerator Los Angeles, United States 5 0% 3 INIA Biosciences, NANOCHON, NeuroBionics
11 Creative Destruction Lab Entrepreneurship program Toronto, Canada 5 0% 1 NANOCHON
12 Right Side Capital Management Micro VC fund San Francisco, United States 5 0%
13 Alchemist Accelerator Startup accelerator San Francisco, United States 5 0%
14 Newchip Accelerator Startup accelerator Austin, United States 5 0%
15 gbeta Startup accelerator Madison, United States 4 0%

Table 3. Biotech startups that raised a seed round in the United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 1,508 78% $5.0B
Software 340 18% $2.0B
Artificial intelligence 213 11% $1.4B
Hardware 61 3% $321.2M
Energy 27 1% $32.6M
Fintech 25 1% $58.2M
Cybersecurity 24 1% $75.8M
Commerce 16 1% $25.9M
Education 13 1% $83.7M

Table 4. Biotech startups that raised a seed round in the United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Seed 1,942 100% $957K

Table 5. Biotech startups that raised a seed round in the United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 172 9%
New York 121 6%
Boston 73 4%
Cambridge 66 3%
San Diego 64 3%
Palo Alto 30 2%
Los Angeles 30 2%
Berkeley 27 1%
Houston 27 1%
Seattle 26 1%
Philadelphia 25 1%
Chicago 24 1%

Table 6. Biotech startups that raised a seed round in the United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 3 1% $11.0M
October 2026 26 10% $279.2M
September 2026 31 12% $204.5M
August 2026 20 7% $102.8M
July 2026 21 8% $43.3M
June 2026 22 8% $122.4M
May 2026 25 9% $85.9M
April 2026 20 7% $50.8M
March 2026 15 6% $193.1M
February 2026 16 6% $45.3M
January 2026 39 15% $451.5M
December 2025 20 7% $146.5M
November 2025 9 3% $43.2M

Table 7. Biotech startups that raised a seed round in the United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 238 12% $1.6B
2025 211 11% $957.3M
2024 165 8% $733.6M
2023 143 7% $479.1M
2022 138 7% $296.5M
2021 147 8% $321.4M

Table 8. Biotech startups that raised a seed round in the United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 342 18%
2020 to 2022 365 19%
2015 to 2019 577 30%
2010 to 2014 344 18%
Before 2010 265 14%

Table 9. Biotech startups that raised a seed round in the United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 1,210 66%
11 to 50 553 30%
51 to 100 43 2%
101 to 250 14 1%
251 to 500 6 0%
501 to 1,000 9 0%
1,001 to 5,000 3 0%
5,001 to 10,000 1 0%
10,001 or more 6 0%

Table 10. Biotech startups that raised a seed round in the United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in the United States whose last round is a seed round are on the list?
1,942, in the file dated 16 November 2026. 267 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 1,942 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised a seed round in the United States: 1,942 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in United States

Other sectors that raised a seed round in United States

Cite: FundingWatcher, 1,942 biotech companies in the United States whose most recent round is a seed round, 16 November 2026. https://fundingwatcher.com/startups/biotech/seed/united-states/